glp-1 discontinuation Adding a receptor agonist was not associated with a lower likelihood of discontinuing existing basal insulin therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation Real-world studies of GLP-1 discontinuation

More recently, one study suggested that GLP-1s function in adipocytes is mediated by GLP-1R and an additional, unknown receptor (Figures 5, 6)

World J Diabetes 15(5):818822 Ferreira JP, Sharma A, Butler J, Packer M, Zannad F, Vasques-Nvoa F et al (2023) Glucagon-like peptide-1 receptor agonists across the spectrum of heart failure

Most sleep changes improve as the body adjusts

Cosmetic labeling regulations vary across different regions, and even small formatting errors can create compliance problems

However, like any cosmetic treatment, there are potential side effects, including mild irritation, redness at the injection site, or allergic reactions (though these are rare)

However, ongoing pharmaceutical innovation and accelerating uptake in markets such as the United States suggest continued growth